get a key
steadybase-$ company EHC
account_id none on file
legal_name Encompass Health Corp
ticker EHC
cik 785161
domain encompasshealth.com
entry_point_account_id none on file
name Encompass Health Corporation
exchange NYSE
sector Health Care
hq Birmingham, AL, United States
calls 3 filings 20 executives 4 family 0
why_nownone on file
calls
2025 EBITDA grew 14.9%, as we gained operating leverage and exercised disciplined expense management.

Feb 6, 2026 / receipt, needs a key / Mark Tark, CEO | earnings call 2026-02-06 | transcript a3732b68-3075-4df3-bccb-83bfbf829336 | chars 3111-3212 | segment 3

Our 2023 adjusted EBITDA increased 18.5% driven by revenue growth and prudent expense management.

Feb 8, 2024 / receipt, needs a key / Doug, other | earnings call 2024-02-08 | transcript 511adea9-5d98-4ddf-8440-1e716eb52a18 | chars 3320-3417 | segment 3

The two countervailing forces that you'll have that will impact that discount on a go-forward basis are what we believe will be the continuing broadening of acuity within MA, which we believe will continue in aggregate to grow faster than fee-for-service. But at the same time, our success in contracting with those MA plans to move more and more of those, we've already added about 80% of the revenues into a per diem basis. put all of that into the mix, and our assumption is that that gap that existed in the second quarter widens a bit in the second half of the year.

Aug 2, 2023 / receipt, needs a key / Doug, other | earnings call 2023-08-02 | transcript 03462b17-63cc-4aee-a127-a9684c12784c | chars 36475-37046 | segment 37

filings
150 to 200 beds to existing hospitals

ir_statement / Sep 15, 2026 / receipt

8 new hospitals with a total of 389 beds

ir_statement / Sep 15, 2026 / receipt

Net pre-opening and ramp-up costs of $18 million to $22 million (inclusive of costs associated with 2027 openings incurred in 2026)

ir_statement / Sep 15, 2026 / receipt

SWB per FTE increase of 3.5% to 4.0%

ir_statement / Sep 15, 2026 / receipt

Common stock repurchase authorization increased to $1 billion

ir_statement / Sep 15, 2026 / receipt

Dividends on common stock $39.2 $71.1 ~ $79

ir_statement / Sep 15, 2026 / receipt

6 to 10 de novos per year

ir_statement / Sep 15, 2026 / receipt

6% to 8% discharge CAGR

ir_statement / Sep 15, 2026 / receipt

80 to 120 bed additions per year

ir_statement / Sep 15, 2026 / receipt

Bed additions • 150-200 beds per year

ir_statement / Sep 15, 2026 / receipt

De novos • 300-500 beds per year

ir_statement / Sep 15, 2026 / receipt

First opening to occur in 2027

ir_statement / Sep 15, 2026 / receipt

executives
familynone on file
upcoming
2026-11-04 earnings call scheduled ir
changes
2026-02-02 director, appointed sec_8k
mcp_package_hint
steadybase-$